Clinical

Dataset Information

0

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction


ABSTRACT: This phase I trial is studying the side effects and best dose of vorinostat in treating patients with metastatic or unresectable solid tumors or lymphoma and liver dysfunction. (closed for accrual as of 04/05/2010) Vorinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Vorinostat may have different effects in patients who have changes in their liver function.

DISEASE(S): Extranodal Marginal Zone B-cell Lymphoma Of Mucosa-associated Lymphoid Tissue,Lymphoma, Large B-cell, Diffuse,Adult Grade Iii Lymphomatoid Granulomatosis,Stage Iv Adult T-cell Leukemia/lymphoma,Stage Iv Adult Diffuse Large Cell Lymphoma,Lymphoma, Large-cell, Immunoblastic,Small Intestine Lymphoma,Stage Iv Adult Diffuse Mixed Cell Lymphoma,Stage Iv Adult Immunoblastic Large Cell Lymphoma,Recurrent Grade 1 Follicular Lymphoma,Sezary Syndrome,Adult Nasal Type Extranodal Nk/t-cell Lymphoma,Splenic Marginal Zone Lymphoma,Mycosis Fungoides,Lymphoma, Mantle-cell,Stage Iv Adult Lymphoblastic Lymphoma,Stage Iii Adult Burkitt Lymphoma,Leukemia-lymphoma, Adult T-cell,Stage Iii Adult Diffuse Small Cleaved Cell Lymphoma,Recurrent Adult Immunoblastic Large Cell Lymphoma,Stage Iv Grade 1 Follicular Lymphoma,Recurrent Adult Burkitt Lymphoma,Stage Iv Mantle Cell Lymphoma,Lymphomatoid Granulomatosis,Primary Central Nervous System Non-hodgkin Lymphoma,Leukemia, T-cell,Lymphoma, T-cell, Peripheral,Lymphoma, Extranodal Nk-t-cell,Plasmablastic Lymphoma,Stage Iv Mycosis Fungoides/sezary Syndrome,Lymphoma, B-cell, Marginal Zone,Burkitt Lymphoma,Stage Iii Mycosis Fungoides/sezary Syndrome,Recurrent Adult Diffuse Small Cleaved Cell Lymphoma,Stage Iii Grade 1 Follicular Lymphoma,Stage Iii Adult Immunoblastic Large Cell Lymphoma,Nodal Marginal Zone B-cell Lymphoma,Stage Iii Marginal Zone Lymphoma,Stage Iii Adult Diffuse Mixed Cell Lymphoma,Recurrent Small Lymphocytic Lymphoma,Lymphoma, T-cell, Cutaneous,Stage Iv Adult Burkitt Lymphoma,Recurrent Marginal Zone Lymphoma,Stage Iii Adult T-cell Leukemia/lymphoma,Recurrent Adult Grade Iii Lymphomatoid Granulomatosis,Lymphoma, Follicular,Waldenstrom Macroglobulinemia,Stage Iii Adult Diffuse Large Cell Lymphoma,Leukemia, Lymphocytic, Chronic, B-cell,Intraocular Lymphoma,Stage Iii Cutaneous T-cell Non-hodgkin Lymphoma,Recurrent Mantle Cell Lymphoma,Recurrent Grade 3 Follicular Lymphoma,Stage Iii Adult Hodgkin Lymphoma,Leukemia,Hodgkin Disease,Recurrent Adult Hodgkin Lymphoma,Primary Central Nervous System Hodgkin Lymphoma,Mycoses,Stage Iii Grade 2 Follicular Lymphoma,Waldenström Macroglobulinemia,Recurrent Adult Lymphoblastic Lymphoma,Angioimmunoblastic T-cell Lymphoma,Stage Iv Marginal Zone Lymphoma,Unspecified Adult Solid Tumor, Protocol Specific,Lymphoma, Large-cell, Anaplastic,Stage Iv Adult Hodgkin Lymphoma,Stage Iii Mantle Cell Lymphoma,Lymphoma, T-cell,Stage Iii Grade 3 Follicular Lymphoma,Stage Iv Grade 3 Follicular Lymphoma,Stage Iv Adult Diffuse Small Cleaved Cell Lymphoma,Immunoblastic Lymphadenopathy,Precursor Cell Lymphoblastic Leukemia-lymphoma,Recurrent Cutaneous T-cell Non-hodgkin Lymphoma,Stage Iv Small Lymphocytic Lymphoma,Lymphoma,Recurrent Mycosis Fungoides/sezary Syndrome,Anaplastic Large Cell Lymphoma,Recurrent Adult Diffuse Mixed Cell Lymphoma,Stage Iii Small Lymphocytic Lymphoma,Recurrent Grade 2 Follicular Lymphoma,Stage Iv Cutaneous T-cell Non-hodgkin Lymphoma,Stage Iv Grade 2 Follicular Lymphoma,Recurrent Adult T-cell Leukemia/lymphoma,Lymphoma, Non-hodgkin,Stage Iii Adult Lymphoblastic Lymphoma,Recurrent Adult Diffuse Large Cell Lymphoma,Lymphoma, B-cell,Cutaneous B-cell Non-hodgkin Lymphoma

PROVIDER: 2041970 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2219879 | ecrin-mdr-crc
| 2046609 | ecrin-mdr-crc
2014-07-07 | GSE56788 | GEO
2014-07-07 | E-GEOD-56788 | biostudies-arrayexpress
2012-12-01 | E-GEOD-35242 | biostudies-arrayexpress
2016-06-30 | E-GEOD-57871 | biostudies-arrayexpress
| 2088557 | ecrin-mdr-crc
2016-06-30 | GSE57871 | GEO
2013-05-08 | E-GEOD-46703 | biostudies-arrayexpress
| 2123001 | ecrin-mdr-crc